Skip to content

Achieving Cardiovascular Health Equity in Community Mental Health: Optimizing Implementation Strategies

Achieving Cardiovascular Health Equity in Community Mental Health: Optimizing Implementation Strategies: An Implementation Trial

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06674616
Enrollment
72
Registered
2024-11-05
Start date
2024-11-07
Completion date
2027-06-30
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk Factors, Serious Mental Illness

Brief summary

In this trial, the investigators will examine the uptake of the evidenced-based IDEAL Goals program, a heart disease risk reduction program, while testing different implementation strategies with our partners in Michigan and Maryland who serve persons with serious mental illness (SMI).

Detailed description

In this trial, the investigators will work with Michigan and Maryland mental health programs to improve the uptake of the 18-month heart disease risk reduction program, IDEAL Goals, to be delivered to persons with SMI enrolled in their behavioral health homes.

Interventions

Replicating Effective Programs (REP), based on Social Learning Theory and Rogers' Diffusion of Innovations, incorporates program packaging, training, and technical support

OTHERCoaching

Coaching is based on the Positive Behavior Interventions and Supports model, addresses staff barriers by building implementers' evidence-based practice (EBP) knowledge, self-efficacy, and skills through clinical support and feedback.

Facilitation addresses potential organizational barriers to delivery, including leadership support and acceptance among other staff.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Community Mental Health Program site staff participants: Inclusion Criteria 1. Ages 18 and Older 2. English Speaking 3. Agree to complete applicable data collection 4. Agree to engage with the program according to their role (e.g., training, IDEAL Goals program delivery).

Design outcomes

Primary

MeasureTime frameDescription
Number of IDEAL Goals sessions received by persons with serious mental illness (SMI) at the community mental health programbaseline to 18 monthsMain effects of implementation strategies defined as those who attend sessions that are assigned to the most intensive strategies (Replicating Effective Programs (REP), Coaching, and Facilitation) compared to the least intensive (REP only). The investigators will use electronic health record data on all clients enrolled in the behavioral health home at a participating organization to assess sessions attended. These individuals are not formally enrolled into the trial; their data, obtained under a waiver of informed consent, comprise this outcome.

Secondary

MeasureTime frameDescription
Number of IDEAL Goals sessions received by persons with serious mental illness (SMI) at the community mental health programbaseline to 18 monthsMarginal effects of implementation strategies defined as those who attend sessions that are assigned to Coaching or Facilitation compared to those not assigned to that same strategy.

Other

MeasureTime frameDescription
Proportion of visits with recommended hypertension activities (e.g. screening, monitoring if have hypertension, medication modification as appropriate) (Exploratory)baseline to 18 months, 30 months
Proportion of visits with recommended diabetes activities (e.g. screening, monitoring if have diabetes, screening exams if have diabetes, medication modification as appropriate) (Exploratory)baseline to 18 months, 30 months
Proportion of visits with recommended dyslipidemia activities (e.g. screening, monitoring if have dyslipidemia, medication modification as appropriate ) (Exploratory)baseline to 18 months, 30 months
Proportion of visits with recommended weight management activities (e.g. counseling) (Exploratory)baseline to 18 months, 30 months
Self-reported tobacco use among persons with SMI at the community mental health program (Exploratory)baseline to 18 months, 30 monthsproportion with self-reported tobacco use recorded by staff in electronic health record
Number of IDEAL Goals sessions received by persons with SMI at the community mental health program at 30 Months (Exploratory)baseline to 30 monthsNumber of sessions received at 30 months
HgbA1c level among persons with SMI at the community mental health program. (Exploratory)baseline to 18 months, 30 months
Lipid values among persons with SMI at the community mental health program (Exploratory)baseline to 18 months, 30 monthslow density lipoprotein (LDL) mg/dl, high density lipoprotein (HDL) mg/dl,, triglycerides mg/dl, and total cholesterol mg/dl,
BMI (kg/m^2) among persons with SMI at the community mental health program pre and post implementation. (Exploratory)baseline to 18 months, 30 monthsBMI in kg/m\^2 based on measured weight in kg and height in meters
Cardiovascular risk in persons with SMI at community mental health programs (Exploratory)baseline to 18 months, 30 monthsAmerican Heart Association (AHA) American College of Cardiology Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score, percent risk, higher scores convey more risk
Estimated cost of delivering the IDEAL Goals program and implementation strategies (Exploratory)baseline to 18 months
Blood pressure (systolic and diastolic) in mmHG among persons with SMI at the community mental health program (Exploratory)baseline to 18 months, 30 months
Proportion of visits with recommended tobacco smoking activities (e.g. assessment, counseling if smoker, pharmacotherapy offered if smoker) (Exploratory)baseline to 18 months, 30 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026